Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Nutt

Showing results (661-670 of 790) with videos related to

Pageof 79
Sort By:
Synapse (New York, N.Y.)|February 1, 2012
Evaluation and initial in vitro and ex vivo characterization of the potential positron emission tomography ligand, BU99008 (2-(4,5-dihydro-1H-imidazol-2-yl)-1- methyl-1H-indole), for the imidazoline₂ binding siteRobin J Tyacke, Amy Fisher, Emma S J Robinson, et al.
Cognition & Emotion|May 7, 2011
Effects of 7.5% CO(2) inhalation on allocation of spatial attention to facial cues of emotional expressionRobbie M Cooper, Jayne E Bailey, Alison Diaper, et al.
European Journal of Pharmacology|December 12, 1996
Evaluation in rat of RS-79948-197 as a potential PET ligand for central alpha 2-adrenoceptorsS P Hume, S Ashworth, A A Lammertsma, et al.
Journal of Clinical Psychopharmacology|July 21, 2006
Depleting serotonin enhances both cardiovascular and psychological stress reactivity in recovered patients with anxiety disordersSimon J C Davies, Sean D Hood, Spilios V Argyropoulos, et al.
Molecular Psychiatry|April 17, 2020
GABA-A receptor differences in schizophrenia: a positron emission tomography study using [<sup>11</sup>C]Ro154513Tiago Reis Marques, Abhishekh H Ashok, Ilinca Angelescu, et al.
The Journal of Clinical Psychiatry|July 20, 2006
Consensus statement and research needs: the role of dopamine and norepinephrine in depression and antidepressant treatmentDavid J Nutt, David S Baldwin, Anita H Clayton, et al.
The British Journal of Psychiatry : the Journal of Mental Science|July 3, 2007
Brain opioid receptor binding in early abstinence from opioid dependence: positron emission tomography studyTim M Williams, Mark R C Daglish, Anne Lingford-Hughes, et al.
Biological Psychiatry|September 29, 2004
Tryptophan depletion reverses the therapeutic effect of selective serotonin reuptake inhibitors in social anxiety disorderSpilios V Argyropoulos, Sean D Hood, Mariona Adrover, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|September 28, 2005
Is there cognitive impairment in clinically 'healthy' abstinent alcohol dependence?Simon J C Davies, Smita A Pandit, Adrian Feeney, et al.
Journal of Psychopharmacology (Oxford, England)|November 10, 2006
Evidence-based guidelines for management of attention-deficit/hyperactivity disorder in adolescents in transition to adult services and in adults: recommendations from the British Association for PsychopharmacologyD J Nutt, K Fone, P Asherson, et al.
Pageof 79

Showing results (661-670 of 790) with videos related to

Sort By:
Pageof 79
Synapse (New York, N.Y.)|February 1, 2012
Evaluation and initial in vitro and ex vivo characterization of the potential positron emission tomography ligand, BU99008 (2-(4,5-dihydro-1H-imidazol-2-yl)-1- methyl-1H-indole), for the imidazoline₂ binding siteRobin J Tyacke, Amy Fisher, Emma S J Robinson, et al.
Cognition & Emotion|May 7, 2011
Effects of 7.5% CO(2) inhalation on allocation of spatial attention to facial cues of emotional expressionRobbie M Cooper, Jayne E Bailey, Alison Diaper, et al.
European Journal of Pharmacology|December 12, 1996
Evaluation in rat of RS-79948-197 as a potential PET ligand for central alpha 2-adrenoceptorsS P Hume, S Ashworth, A A Lammertsma, et al.
Journal of Clinical Psychopharmacology|July 21, 2006
Depleting serotonin enhances both cardiovascular and psychological stress reactivity in recovered patients with anxiety disordersSimon J C Davies, Sean D Hood, Spilios V Argyropoulos, et al.
Molecular Psychiatry|April 17, 2020
GABA-A receptor differences in schizophrenia: a positron emission tomography study using [<sup>11</sup>C]Ro154513Tiago Reis Marques, Abhishekh H Ashok, Ilinca Angelescu, et al.
The Journal of Clinical Psychiatry|July 20, 2006
Consensus statement and research needs: the role of dopamine and norepinephrine in depression and antidepressant treatmentDavid J Nutt, David S Baldwin, Anita H Clayton, et al.
The British Journal of Psychiatry : the Journal of Mental Science|July 3, 2007
Brain opioid receptor binding in early abstinence from opioid dependence: positron emission tomography studyTim M Williams, Mark R C Daglish, Anne Lingford-Hughes, et al.
Biological Psychiatry|September 29, 2004
Tryptophan depletion reverses the therapeutic effect of selective serotonin reuptake inhibitors in social anxiety disorderSpilios V Argyropoulos, Sean D Hood, Mariona Adrover, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|September 28, 2005
Is there cognitive impairment in clinically 'healthy' abstinent alcohol dependence?Simon J C Davies, Smita A Pandit, Adrian Feeney, et al.
Journal of Psychopharmacology (Oxford, England)|November 10, 2006
Evidence-based guidelines for management of attention-deficit/hyperactivity disorder in adolescents in transition to adult services and in adults: recommendations from the British Association for PsychopharmacologyD J Nutt, K Fone, P Asherson, et al.
Pageof 79